O2h Ventures logo

O2h Ventures

Europe, Cambridgeshire, United Kingdom, Hauxton

Description

Investment firm which in backing biotech, offering investors the opportunity to back promising medical innovations via the EIS and SEIS.

Investor Profile

O2h Ventures has made 34 investments, with 3 in the past 12 months and 32% as lead.

Stage Focus

  • Seed (47%)
  • Series Unknown (15%)
  • Series A (9%)
  • Pre Seed (9%)
  • Series C (6%)
  • Series B (6%)
  • Equity Crowdfunding (3%)
  • Convertible Note (3%)
  • Grant (3%)

Country Focus

  • United Kingdom (94%)
  • Hungary (6%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Medical
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Life Science
  • Saas
  • Software
  • Delivery
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does O2h Ventures frequently co-invest with?

Martlet Capital
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 3
Wren Capital
Europe, England, United Kingdom, London
Co-Investments: 5
ACF Investors
Europe, Sheffield, United Kingdom, Sheffield
Co-Investments: 7
SyndicateRoom
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 4
Cambridge Angels group
Europe, England, United Kingdom, London
Co-Investments: 5
Accel
North America, California, United States, Palo Alto
Co-Investments: 2
University of Cambridge Enterprise
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 4
MA
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 8
R42 Group
North America, California, United States, Stanford
Co-Investments: 3
Parkwalk Advisors
Europe, England, United Kingdom, London
Co-Investments: 4

Which angels does O2h Ventures often collaborate with?

VG
Europe, England, United Kingdom, London
Shared Deals: 1
CD
North America, California, United States, San Francisco
Shared Deals: 1
DF
Europe, Cambridgeshire, United Kingdom, Cambridge
Shared Deals: 1
ED
North America, New York, United States, New York
Shared Deals: 1
PG
Europe, England, United Kingdom, London
Shared Deals: 1
DC
Europe, Cambridgeshire, United Kingdom, Cambridge
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 6

What are some of recent deals done by O2h Ventures?

Monument Therapeutics

Cambridge, Cambridgeshire, United Kingdom

Monument Therapeutics develops products to treat serious diseases of the central nervous system.

BiotechnologyHealth CarePharmaceutical
Series UnknownFeb 25, 2025
Amount Raised: $1,073,430
Atelerix

Newcastle, Newcastle upon Tyne, United Kingdom

Atelerix provides storage and transportation of human cells at room temperature to companies.

BiotechnologyHealth CareMedical
Series UnknownJan 28, 2025
Amount Raised: $932,269
Healx

Cambridge, Cambridgeshire, United Kingdom

Healx is a rare disease biotechnology company that uses generative AI for drug discovery.

Artificial Intelligence (AI)BiopharmaBiotechnologyHealth CareLife ScienceMedical
Series CAug 1, 2024
Amount Raised: $47,000,000
ViaNautis

Cambridge, Cambridgeshire, United Kingdom

ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers.

BiopharmaBiotechnologyMedical
Series ANov 13, 2023
Amount Raised: $24,558,590
Pencil Biosciences

Alderley Park, Cheshire, United Kingdom

Pencil Biosciences is a novel gene modulation company.

BiotechnologyHealth Care
SeedSep 28, 2023
Amount Raised: $6,834,369
Kuano

London, England, United Kingdom

Kuano provides innovative quantum and AI solutions for drug discovery and design.

Artificial Intelligence (AI)Biotechnology
SeedSep 12, 2023
Amount Raised: $2,248,426
PharmEnable

Cambridge, Cambridgeshire, United Kingdom

PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.

BiotechnologyLife ScienceMedicalPharmaceutical
SeedMay 22, 2023
Amount Raised: $7,460,367
Five Alarm Bio

Hauxton, Cambridgeshire, United Kingdom

Five Alarm Bio is a drug discovery company.

Pharmaceutical
SeedFeb 27, 2023
Amount Raised: $603,109
Qkine

Cambridge, Cambridgeshire, United Kingdom

Qkine is a specialist developer and manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications

Alternative ProteinBiotechnologyLife Science
Series BDec 15, 2022
Amount Raised: $5,242,049
Alevin Therapeutics

Cambridge, Cambridgeshire, United Kingdom

Alevin Therapeutics is creating breakthrough approaches to safe and effective medicines for patients with life-threatening diseases.

Biotechnology
SeedJul 29, 2022